Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis

Fig. 4

The effects of Na+/H+ exchanger inhibitor (cariporide) on empagliflozin decreased migration in atrial fibroblasts. Photographs and averaged data present the results of migration assay for empagliflozin (1 μmol/L)-treated atrial fibroblasts treated with or without cariporide (10 μmol/L). Upper panels display the initial scratch (baseline) in different groups. Lower panels display the images 6 h after the scratch was created (after migration) (n = 6 independent experiments, statistic test by one-way repeated measures ANOVA). * p < 0.05, # p < 0.01, $ p < 0.005

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840